CCL5 and acute myeloid leukemia: Specifically, FST overexpression in ML‐2 cells was shown to upregulate genes involved in MAPK/ERK pathway including RET, IL2RA, and CCL5, of which IL2RA and CCL5 were shown to highly express in human AML compared with normal hematopoietic tissues (Bloodspot website: http://servers.binf.ku.dk/bloodspot/) and were associated with poor overall survival in AML patients.